Trial Profile
A Randomised, Comparative, Single Dose, Open Study to Compare the Pharmacokinetics and Safety of Optivate and Haemate P in Patients With Different Types of Von Willebrand Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Pharmacokinetics
- Sponsors Bio Products Laboratory
- 29 Sep 2014 New trial record